<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36182048</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>25</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1521-7035</ISSN><JournalIssue CitedMedium="Internet"><Volume>245</Volume><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Clinical immunology (Orlando, Fla.)</Title><ISOAbbreviation>Clin Immunol</ISOAbbreviation></Journal><ArticleTitle>Protracted stress-induced hypocortisolemia may account for the clinical and immune manifestations of Long COVID.</ArticleTitle><Pagination><StartPage>109133</StartPage><MedlinePgn>109133</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.clim.2022.109133</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1521-6616(22)00214-5</ELocationID><Abstract><AbstractText>About one out of eight people to convalesce from COVID-19 suffer from the so called Long COVID, a syndrome of non-specific symptoms with unclear pathogenesis. In a recent study published in Cell Long COVID participants reporting respiratory symptoms had low cortisol levels. In an as yet unpublished analysis from Yale University low plasma cortisol levels discriminated Long COVID from asymptomatic convalescent or healthy non-infected controls. Although various immune perturbations were present in Long COVID, low levels of cortisol were prominent and strikingly, depression and anxiety were increased. It has become clear that Long COVID features may be similar to those described in myalgic encephalomyelitis/chronic fatigue syndrome, post-SARS sickness syndrome, and various chronic stress syndromes which have been linked to hypocortisolemia. Notably, lack of response of the hypothalamic-pituitary-adrenal axis to hypocortisolemia shows a suppressed axis in Long COVID. We suggest that the inability of hypothalamic-pituitary-adrenal axis to recover after the acute illness, perhaps due to protracted stress in predisposed individuals, may represent the pathogenetic basis of the Long COVID-associated clinical and immunological manifestations.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yavropoulou</LastName><ForeName>Maria P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>1(st) Department of Propaedeutic and Internal Medicine, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsokos</LastName><ForeName>George C</ForeName><Initials>GC</Initials><AffiliationInfo><Affiliation>Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chrousos</LastName><ForeName>George P</ForeName><Initials>GP</Initials><AffiliationInfo><Affiliation>University Research Institute of Maternal and Child Health and Precision Medicine and UNESCO Chair on Adolescent Health Care, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sfikakis</LastName><ForeName>Petros P</ForeName><Initials>PP</Initials><AffiliationInfo><Affiliation>1(st) Department of Propaedeutic and Internal Medicine, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece. Electronic address: psfikakis@med.uoa.gr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Immunol</MedlineTA><NlmUniqueID>100883537</NlmUniqueID><ISSNLinking>1521-6616</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>WI4X0X7BPJ</RegistryNumber><NameOfSubstance UI="D006854">Hydrocortisone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010913" MajorTopicYN="N">Pituitary-Adrenal System</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007030" MajorTopicYN="N">Hypothalamo-Hypophyseal System</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006854" MajorTopicYN="N">Hydrocortisone</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015673" MajorTopicYN="Y">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adrenals</Keyword><Keyword MajorTopicYN="N">Chronic fatigue syndrome</Keyword><Keyword MajorTopicYN="N">Hypocortisolemia</Keyword><Keyword MajorTopicYN="N">Hypothalamic-pituitary-adrenal axis</Keyword><Keyword MajorTopicYN="N">Long Covid-19</Keyword><Keyword MajorTopicYN="N">Pathophysiology</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>1</Day><Hour>19</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36182048</ArticleId><ArticleId IdType="pmc">PMC9519365</ArticleId><ArticleId IdType="doi">10.1016/j.clim.2022.109133</ArticleId><ArticleId IdType="pii">S1521-6616(22)00214-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>COVID is here to stay: countries must decide how to adapt. Nature. 2022;601:165. doi: 10.1038/d41586-022-00057-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-022-00057-y</ArticleId><ArticleId IdType="pubmed">35013606</ArticleId></ArticleIdList></Reference><Reference><Citation>Brightling C.E., Evans R.A. Long COVID: which symptoms can be attributed to SARS-CoV-2 infection? Lancet. 2022;400:411&#x2013;413. doi: 10.1016/S0140-6736(22)01385-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01385-X</ArticleId><ArticleId IdType="pmc">PMC9352303</ArticleId><ArticleId IdType="pubmed">35933996</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T., Hittle M., Goodman S.N. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw. Open. 2021;4 doi: 10.1001/jamanetworkopen.2021.11417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S., Merad M. Pathological sequelae of long-haul COVID. Nat. Immunol. 2022;23:194&#x2013;202. doi: 10.1038/s41590-021-01104-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>PHOSP-COVID Collaborative Group Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir. Med. 2022;10:761&#x2013;775. doi: 10.1016/S2213-2600(22)00127-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00127-8</ArticleId><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering A.V., van Zon S.K.R., Olde Hartman T.C., Rosmalen J.G.M., I. Lifelines Corona Research Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 2022;400:452&#x2013;461. doi: 10.1016/S0140-6736(22)01214-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., Ng R.H., Wang K., Choi J., Li S., Hong S., Zhang R., Xie J., Kornilov S.A., Scherler K., Pavlovitch-Bedzyk A.J., Dong S., Lausted C., Lee I., Fallen S., Dai C.L., Baloni P., Smith B., Duvvuri V.R., Anderson K.G., Li J., Yang F., Duncombe C.J., McCulloch D.J., Rostomily C., Troisch P., Zhou J., Mackay S., DeGottardi Q., May D.H., Taniguchi R., Gittelman R.M., Klinger M., Snyder T.M., Roper R., Wojciechowska G., Murray K., Edmark R., Evans S., Jones L., Zhou Y., Rowen L., Liu R., Chour W., Algren H.A., Berrington W.R., Wallick J.A., Cochran R.A., Micikas M.E., Unit I.S.-S.C.-B., Wrin T., Petropoulos C.J., Cole H.R., Fischer T.D., Wei W., Hoon D.S.B., Price N.D., Subramanian N., Hill J.A., Hadlock J., Magis A.T., Ribas A., Lanier L.L., Boyd S.D., Bluestone J.A., Chu H., Hood L., Gottardo R., Greenberg P.D., Davis M.M., Goldman J.D., Heath J.R. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895 e820. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanczkowski W., Evert K., Stadtmuller M., Haberecker M., Laks L., Chen L.S., Frontzek K., Pablik J., Hantel C., Beuschlein F., Kurth T., Gruber S., Aguzzi A., Varga Z., Bornstein S.R. COVID-19 targets human adrenal glands. Lancet Diabetes Endocrinol. 2022;10:13&#x2013;16. doi: 10.1016/S2213-8587(21)00291-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(21)00291-6</ArticleId><ArticleId IdType="pmc">PMC8601687</ArticleId><ArticleId IdType="pubmed">34801110</ArticleId></ArticleIdList></Reference><Reference><Citation>Yavropoulou M.P, Filippa M.G., Mantzou A., Ntziora F., Mylona M., Tektonidou M.G., Vlachogiannis N.I., Paraskevis D., Kaltsas G.A., Chrousos G.P., Sfikakis P.P. Alterations in cortisol and interleukin-6 secretion in patients with COVID-19 suggestive of neuroendocrine-immune adaptations. Endocrine. 2022;75:317&#x2013;327. doi: 10.1007/s12020-021-02968-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-021-02968-8</ArticleId><ArticleId IdType="pmc">PMC8765492</ArticleId><ArticleId IdType="pubmed">35043384</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J., Wood J., Jaycox J., et al. Distinguishing features of Long COVID identified through immune profiling. medRxiv preprint. 2022 doi: 10.1101/2022.08.09.22278592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.08.09.22278592</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Clayton E.W. Beyond myalgic encephalomyelitis/chronic fatigue syndrome: an IOM report on redefining an illness. JAMA. 2015;313:1101&#x2013;1102. doi: 10.1001/jama.2015.1346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.1346</ArticleId><ArticleId IdType="pubmed">25668027</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancini D.M., Brunjes D.L., Lala A., Trivieri M.G., Contreras J.P., Natelson B.H. Use of cardiopulmonary stress testing for patients with unexplained dyspnea post-coronavirus disease. JACC Heart Fail. 2021;9:927&#x2013;937.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8629098</ArticleId><ArticleId IdType="pubmed">34857177</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedor C., Freitag H., Meyer-Arndt L., Wittke K., Hanitsch L.G., Zoller T., Steinbeis F., Haffke M., Rudolf G., Heidecker B., Bobbert T., Spranger J., Volk H.D., Skurk C., Konietschke F., Paul F., Behrends U., Bellmann-Strobl J., Scheibenbogen C. A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nat. Commun. 2022;13:5104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9426365</ArticleId><ArticleId IdType="pubmed">36042189</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonilla H., Quach A., Tiwari A.E., et al. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is common in post-acute sequelae of SARS-CoV-2 infection (PASC): Results from a post-COVID-19 multidisciplinary clinic. medRxiv preprint. 2022 doi: 10.1101/2022.08.03.22278363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.08.03.22278363</ArticleId><ArticleId IdType="pmc">PMC9998690</ArticleId><ArticleId IdType="pubmed">36908615</ArticleId></ArticleIdList></Reference><Reference><Citation>Crofford L.J., Pillemer S.R., Kalogeras K.T., Cash J.M., Michelson D, Kling M.A., Sternberg E.M., Gold P.W., Chrousos G.P., Wilder R.L. Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum. 1994;37:1583&#x2013;1592. doi: 10.1002/art.1780371105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780371105</ArticleId><ArticleId IdType="pubmed">7980669</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruber L.M., Nanda S., Nippoldt T., Chang A.Y., Bancos I. Secondary Adrenal Insufficiency and Growth Hormone Deficiency in Patients with Fibromyalgia. J Pain Res. 2021;14:1323&#x2013;1329. doi: 10.2147/JPR.S302291.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JPR.S302291</ArticleId><ArticleId IdType="pmc">PMC8141402</ArticleId><ArticleId IdType="pubmed">34040435</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y.J., Ko Y.C., Chow L.H., Hsiao F.J., Liu H.Y., Wang P.N., Chen W.T. Salivary cortisol is associated with cognitive changes in patients with fibromyalgia. Sci Rep. 2021;11:1311. doi: 10.1038/s41598-020-79349-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-79349-0</ArticleId><ArticleId IdType="pmc">PMC7809444</ArticleId><ArticleId IdType="pubmed">33446677</ArticleId></ArticleIdList></Reference><Reference><Citation>Griep E.N., Boersma J.W., de Kloet E.R. Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. J Rheumatol. 1993;20:469&#x2013;474.</Citation><ArticleIdList><ArticleId IdType="pubmed">8386766</ArticleId></ArticleIdList></Reference><Reference><Citation>Demitrack M.A., Dale J.K., Straus S.E., Laue L., Listwak S.J., Kruesi M.J., Chrousos G.P., Gold P.W. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab. 1991;73:1224&#x2013;1234. doi: 10.1210/jcem-73-6-1224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jcem-73-6-1224</ArticleId><ArticleId IdType="pubmed">1659582</ArticleId></ArticleIdList></Reference><Reference><Citation>Leow M.K., Kwek D.S., Ng A.W., Ong K.C., Kaw G.J., Lee L.S. Hypocortisolism in survivors of severe acute respiratory syndrome (SARS) Clin Endocrinol (Oxf) 2005;63:197&#x2013;202. doi: 10.1111/j.1365-2265.2005.02325.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2265.2005.02325.x</ArticleId><ArticleId IdType="pmc">PMC7188349</ArticleId><ArticleId IdType="pubmed">16060914</ArticleId></ArticleIdList></Reference><Reference><Citation>Chrousos G.P., Kaltsas Kaltsas. Post-SARS sickness syndrome manifestations and endocrinopathy: how, why, and so what? Clin Endocrinol (Oxf) 2005;63:363&#x2013;365. doi: 10.1111/j.1365-2265.2005.02361.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2265.2005.02361.x</ArticleId><ArticleId IdType="pmc">PMC7162060</ArticleId><ArticleId IdType="pubmed">16181227</ArticleId></ArticleIdList></Reference><Reference><Citation>Chrousos, G.P., Gold P.W. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA. 1992;267:1244&#x2013;1252. doi: 10.1001/jama.1992.03480090092034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1992.03480090092034</ArticleId><ArticleId IdType="pubmed">1538563</ArticleId></ArticleIdList></Reference><Reference><Citation>Charmandari E., Nicolaides N.C., Chrousos G.P. Adrenal insufficiency. Lancet. 2014;383:2152&#x2013;2167. doi: 10.1016/S0140-6736(13)61684-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(13)61684-0</ArticleId><ArticleId IdType="pubmed">24503135</ArticleId></ArticleIdList></Reference><Reference><Citation>Papanicolaou D.A., Tsigos C., Oldfield E.H., Chrousos G.P. Acute glucocorticoid deficiency is associated with plasma elevations of interleukin-6: does the latter participate in the symptomatology of the steroid withdrawal syndrome and adrenal insufficiency? J Clin Endocrinol Metab. 1996;81:2303&#x2013;2306. doi: 10.1210/jcem.81.6.8964868.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jcem.81.6.8964868</ArticleId><ArticleId IdType="pubmed">8964868</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippa M.G., Tektonidou M.G., Mantzou A., Kaltsas G.A., Chrousos G.P., Sfikakis P.P., Yavropoulou M.P. Adrenocortical dysfunction in rheumatoid arthritis: A narrative review and future directions. Eur J Clin Invest. 2022;52:e13635. doi: 10.1111/eci.13635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.13635</ArticleId><ArticleId IdType="pubmed">34097322</ArticleId></ArticleIdList></Reference><Reference><Citation>Yavropoulou M.P., Filippa M.G., Panopoulos S., Spanos E., Spanos G., Tektonidou M.G., Sfikakis P.P. Impaired adrenal cortex reserve in patients with rheumatic and musculoskeletal diseases who relapse upon tapering of low glucocorticoid dose. Clin Exp Rheumatol. 2022;4:1789&#x2013;1792. doi: 10.55563/clinexprheumatol/x78tko.</Citation><ArticleIdList><ArticleId IdType="doi">10.55563/clinexprheumatol/x78tko</ArticleId><ArticleId IdType="pubmed">35699085</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>